Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News


Novartis: New cost-saving unit will not target manufacturing network

29-Jan-2015 - Novartis has divested, restructured, or mothballed 24 manufacturing plants since 2010 but says its new NBS cost-saving business will not focus on streamlining and consolidating sites.

Hospira 'committed to quality' as total recall count hits 40 since 2012

27-Jan-2015 - A human hair found in a vial of Sodium Chloride Injection has led to the fortieth recall in three years for Hospira.

Halal and Kosher stamps of approval for pregnancy drug

26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an oral prescription drug in the US.

Teva: More biomanufacturing space needed to tap biologics opportunities

21-Jan-2015 - Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.

Cost, not compliance, behind Clayton closure, says Hospira

19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.  

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

J&J to receive almost €50m in grants to help manufacture Ebola vaccines

19-Jan-2015 - EFPIA has given J&J subsidiary Crucell Holland and partner Bavarian Nordic €47.6m ($54.9m) to accelerate development of an candidate Ebola vaccine.

Fresenius Kabi NY aseptic plant upgraded by USFDA

15-Jan-2015 - A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

US solvent disposal definition will encourage recycling, says SOCMA

14-Jan-2015 - Critical solvents used by the pharmaceutical manufacturers have been excluded from the EPA's final ruling on waste disposal, in a move welcomed by a US industry group.

Micronization getting bigger: Fareva invests in capacity citing increasing demand

13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.

US FDA approves Impax’s Parkinson’s disease treatment following resolved manufacturing issues

12-Jan-2015 - Almost two years since it was first rejected , Impax Pharmaceuticals said late last week that the US FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.

Shire takes $5bn gamble on NPS' hormone replacement PDUFA decision

12-Jan-2015 - Shire says its $5.2bn (€4.4bn) acquisition of NPS Pharmaceuticals is a calculated risk, coming just days before the US FDA decides whther to approve the hormone replacement therapy Natpara.

Argos looks to disposables for manufacturing personalized immunotherapies

07-Jan-2015 - Cancer and infectious disease immunotherapy developer Argos Therapeutics is collaborating with Saint-Gobain’s Performance Plastics division, to design, integrate and scale production of a range of disposables for use in the manufacturing of Argos’ lead product candidate.

Sartorius sells Intec to focus on bioprocessing and lab

05-Jan-2015 - Sartorius AG has announced plans to sell its industrial weighing and control tech business, Intec, as part of a long-term strategy to focus on bioprocessing and laboratory equipment.

Professional liaisons: ‘Tinder for healthcare’ shakes up conferences

05-Jan-2015 - Mobile software modelled on the dating app Tinder could help life science investors find new partners according to networking firm PostHealthcare.

Interactive Quiz!

The Big Pharma Big Quiz of the year, 2014

23-Dec-2014 - The year is over so time to reflect on who bought who, who sued who and who had what approved in our 2014 review quiz.

AstraZeneca API plant set to shut by 2017 as Patent Cliff strikes again

18-Dec-2014 - An AstraZeneca API plant in Bristol, UK will close its doors within two years due to patent expirations of its cholesterol-lowering blockbuster Crestor.

Immunotherapy in the UK? National manufacturing site backed by GE

17-Dec-2014 - GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.

Asian API exporters looking to process management IT systems, says Werum

16-Dec-2014 - Asian API makers are turning to ‘out-of-the-box’ Manufacturing Execution Systems (MES) to help manage documentation and control quality, according to IT solutions Werum.

After AZ R&D exit, CMOs anxious to keep pharma in the country

11-Dec-2014 - Pharma companies have called on the Swedish government to prevent manufacturing going the way of R&D and leaving the country, after AstraZeneca closed its research in Lund in 2012.

Want to work for Pfizer? Get ready for ‘American Idol’ audition

10-Dec-2014 - Pfizer has revealed a unique way of hiring employees in Sweden it compares to “American Idol” auditions.

From CPHI India

Eager-to-please Indian manufacturers creating GMP chaos says expert

08-Dec-2014 - Cultural differences and broken promises are behind Indian GMP failures and acute generics shortages in the UK, according to one pharmaceutical distributor.

If only syphilis was really this cute! Win a dose in time for Christmas

05-Dec-2014 - How many drugs are prescribed in the North Pole? Have a guess and win a cuddly giant microbe in our Christmas Competition.

Flu vaccine underwent 35 QA/QC tests in Italy death probe, says Novartis

05-Dec-2014 - Novartis has spoken about the extensive safety testing at its production sites after its seasonal flu vaccine Fluad was found to be unconnected to 19 deaths in Italy.


'On Immunity': enter’s free book giveaway

'On Immunity': enter’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social...

Resistance is…years away: New compound could delay post antibiotic era

Resistance is…years away: New compound could delay post antibiotic era

Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape...

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk...

Gilead strikes back at AbbVie with exclusive payer deal for hep C drug

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of...

Not prepared for track & trace? US FDA grants amnesty until May

Not prepared for track & trace? US FDA grants amnesty until May

The US FDA will give drugmakers and distributors until May to comply with new track and trace...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...